SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001019687-15-001702
Filing Date
2015-04-30
Accepted
2015-04-30 16:15:40
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A xenetic_10ka-123114.htm 10-K/A 180502
2 CODE OF BUSINESS CONDUCT AND ETHICS xenetic_10ka-ex14.htm EX-14 36140
3 CERTIFICATION xenetic_10ka-ex3103.htm EX-31.3 8006
4 CERTIFICATION xenetic_10ka-ex3104.htm EX-31.4 7968
5 CERTIFICATION xenetic_10ka-ex3202.htm EX-32.2 3662
  Complete submission text file 0001019687-15-001702.txt   237479
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-178082 | Film No.: 15818788
SIC: 2834 Pharmaceutical Preparations